ESC 365 - Frequency, management and outcomes of patients with stable coronary artery disease eligible for COMPASS. An analysis of the CLARIFY registry.

ESC Premium Access

Frequency, management and outcomes of patients with stable coronary artery disease eligible for COMPASS. An analysis of the CLARIFY registry.

Session: Antithrombotic therapy for coronary artery disease: opportunities and challenges

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor E. Sorbets (Paris, FR)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Emmanuel Sorbets

Hospital Hotel-Dieu, Paris (France)

3 presentations

0 follower

3 more presentations in this session

State of the Art - New options in antithrombotic therapy for coronary artery disease

Speaker: Professor K. Newby (Durham, US)

Atherothrombotic risk and outcomes following guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome:a post-hoc analysis of the TROPICAL-ACS trial

Speaker: Assistant Professor K. Rizas (Munich, DE)

Secondary prevention in 2030: will antiplatelets or anticoagulants prevail?

Speaker: Professor D. Angiolillo (Jacksonville, US)

Access the full session

Antithrombotic therapy for coronary artery disease: opportunities and challenges

Speakers: Doctor E. Sorbets, Professor K. Newby, Assistant Professor K. Rizas, Professor D. Angiolillo

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources